{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-262025-03-261111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-262025-03-261111100
Download SVG
Download PNG
Download CSV

Morgan Stanley rates Tenet Healthcare overweight with a target of 165 dollars

Morgan Stanley has initiated coverage on Tenet Healthcare with an Overweight rating and a price target of $165, citing the company's strategic positioning in outpatient services and effective management of its acute care business. Despite a 22% stock decline since the election, analysts remain optimistic about Tenet's growth potential, bolstered by significant debt reduction and improved liquidity. Fitch Ratings upgraded Tenet's Issuer Default Rating to 'BB-', reflecting its enhanced competitive position and anticipated EBITDA growth.

ubs raises ollies stock target on strong fourth quarter performance

UBS has raised the price target for Ollie’s Bargain Outlet to $123, citing strong Q4 results and a resilient performance amid challenging consumer conditions. The company reported a 2.8% increase in same-store sales and plans to open 75 new stores in 2025, reflecting confidence in its growth potential. Other analysts have also expressed optimism, with price targets ranging from $124 to $133, highlighting Ollie’s ability to capture market share despite external challenges.

ubs lowers five below price target while maintaining buy rating

UBS has lowered its price target for Five Below stock to $110 from $150 while maintaining a Buy rating, reflecting a cautious outlook amid challenges like tariffs. Despite a -27.98% year-to-date return, the retailer shows signs of resilience with an 8.91% revenue growth and improving comparable store sales. Five Below is focusing on a turnaround strategy, enhancing product offerings, and investing in marketing and employee wages to improve customer experience.

ubs maintains neutral rating on alphabet following 32 billion dollar acquisition of wiz

UBS has maintained a Neutral rating on Alphabet Inc. with a target price of $209 following its $32 billion acquisition of cybersecurity firm Wiz, which is significantly higher than previous valuations. While Alphabet shows strong financial health, concerns about return on investment and regulatory issues may temper investor sentiment. Other analysts, including BMO and Goldman Sachs, have given positive ratings, highlighting the strategic potential of the acquisition to enhance Alphabet's cloud security capabilities.

ubs downgrades sunnova energy shares amid liquidity concerns and financial losses

UBS has downgraded Sunnova Energy International Inc. from Buy to Neutral, slashing its price target from $5.00 to $0.65, as the company faces liquidity concerns with only $2 million in unrestricted cash. Sunnova's stock has plummeted over 90% in the past year, and analysts worry about its ability to manage $8.3 billion in debt amid an uncertain political climate affecting tax credits. Despite a 17% revenue increase to $840 million, the company missed earnings expectations, prompting several firms to adjust their ratings downward.

Deutsche Bank raises Snowflake stock target amid strong financial performance

Deutsche Bank has raised its price target for Snowflake Inc. to $220, maintaining a Buy rating, following a strong fourth-quarter earnings report that exceeded expectations. The company reported a 30.3% revenue growth and a gross profit margin of 67.3%, with analysts optimistic about its future profitability and growth trajectory. Other firms, including Stifel and RBC Capital Markets, have also increased their targets, reflecting confidence in Snowflake's strategic initiatives and market position.

ubs lowers first solar price target but maintains buy recommendation

UBS has lowered its price target for First Solar from $360 to $285 while maintaining a buy recommendation, despite the stock's 32.7% decline over the past six months. The company forecasts revenues of $5.55 billion for 2025, slightly above expectations, and has shown strong sales growth of 21.8% with a healthy gross margin of 46.5%. Analysts from various firms have adjusted their price targets, reflecting diverse perspectives on First Solar's future prospects.

ubs lowers price target for on holding while maintaining buy rating

UBS has lowered its price target for On Holding AG to $65 from $67 while maintaining a Buy rating, reflecting confidence in the company's strong sales growth and margins. Analysts expect at least 26% year-over-year revenue growth for 2025, despite the slight target adjustment. Other firms have also issued positive ratings, highlighting On Holding's brand strength and market positioning, as investors await the upcoming earnings report.

ubs maintains buy rating on inspire medical with target price of 265

UBS has reaffirmed a Buy rating on Inspire Medical Systems (NYSE: INSP) with a price target of $265, reflecting strong Wall Street sentiment amid the company's robust financial health and growth potential. Despite an ongoing Department of Justice investigation, analysts remain optimistic, citing a significant earnings beat and positive guidance for 2025, with expected sales of $940-955 million and EPS between $2.10 and $2.20. Other firms, including RBC Capital Markets and Piper Sandler, also maintain favorable ratings, underscoring the company's operational excellence and resilience.

ubs raises tempur sealy stock target to seventy eight dollars

UBS has raised its price target for Tempur Sealy International Inc. to $78, maintaining a Buy rating, citing strong stock momentum and strategic initiatives that could enhance earnings. The company is focused on refining retail operations at Mattress Firm and is expected to exceed synergy targets post-acquisition, with analysts projecting significant growth in earnings per share. Recent financial results show a 2% increase in net sales to $1.3 billion and a 14% rise in GAAP EPS to $0.73 in Q3 2024, indicating robust performance.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.